An Open-label Randomized Phase 2 study of Durvalumab Alone or in Combination with Tremelimumab in Patients with Advanced Germ Cell Tumors (APACHE): Results from the First Planned Interim Analysis
Articolo
Data di Pubblicazione:
2019
Citazione:
An Open-label Randomized Phase 2 study of Durvalumab Alone or in Combination with Tremelimumab in Patients with Advanced Germ Cell Tumors (APACHE): Results from the First Planned Interim Analysis / Necchi, A; Giannatempo, P; Raggi, D; Mariani, L; Colecchia, M; Fare, E; Monopoli, F; Calareso, G; Ali, Sm; Ross, Js; Chung, Jh; Salvioni, R. - In: EUROPEAN UROLOGY. - ISSN 0302-2838. - 75:1(2019), pp. 201-203. [10.1016/j.eururo.2018.09.010]
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Necchi, A; Giannatempo, P; Raggi, D; Mariani, L; Colecchia, M; Fare, E; Monopoli, F; Calareso, G; Ali, Sm; Ross, Js; Chung, Jh; Salvioni, R
Link alla scheda completa:
Pubblicato in: